Atrás
Rango del Día
$32.50
$37.69
Rango de 52 Semanas
$32.50
$46.64
Volumen
1,000
Promedio 50D / 200D
$35.83
/
$38.53
Cierre Anterior
$37.69
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 8.3 | 0.4 |
| P/B | 0.7 | 2.9 |
| ROE % | 8.2 | 3.8 |
| Net Margin % | 1.8 | 3.9 |
| Rev Growth 5Y % | 7.5 | 10.0 |
| D/E | 0.6 | 0.2 |
Puntos Clave
Revenue grew 7.51% annually over 5 years — modest growth
Earnings declined -21.93% over the past year
Generating 396.38M in free cash flow
P/E of 8.34 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.85%
Cash machine — converts 171.11% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
7.51%
Revenue (1Y)-8.34%
Earnings (1Y)-21.93%
FCF Growth (3Y)11.49%
Calidad
Return on Equity
8.23%
ROIC7.28%
Net Margin1.75%
Op. Margin3.45%
Seguridad
Debt / Equity
0.59
Current Ratio1.18
Interest Coverage4.73
Valoración
P/E Ratio
8.34
P/B Ratio0.65
EV/EBITDA7.64
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -8.34% | Revenue Growth (3Y) | -0.41% |
| Earnings Growth (1Y) | -21.93% | Earnings Growth (3Y) | -8.34% |
| Revenue Growth (5Y) | 7.51% | Earnings Growth (5Y) | 3.86% |
| Profitability | |||
| Revenue (TTM) | 13.21B | Net Income (TTM) | 231.66M |
| ROE | 8.23% | ROA | 2.96% |
| Gross Margin | 13.35% | Operating Margin | 3.45% |
| Net Margin | 1.75% | Free Cash Flow (TTM) | 396.38M |
| ROIC | 7.28% | FCF Growth (3Y) | 11.49% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 1.18 |
| Interest Coverage | 4.73 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 8.34 | P/B Ratio | 0.65 |
| P/S Ratio | 0.15 | PEG Ratio | -0.62 |
| EV/EBITDA | 7.64 | Dividend Yield | 0.04% |
| Market Cap | 1.93B | Enterprise Value | 3.48B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 13.21B | 14.41B | 13.32B | 11.90B | 9.89B |
| Net Income | 231.66M | 296.71M | 275.74M | 224.64M | 199.09M |
| EPS (Diluted) | 4.70 | 6.18 | 5.78 | 5.08 | 4.86 |
| Gross Profit | 1.76B | 1.78B | 1.70B | 1.38B | 1.07B |
| Operating Income | 455.58M | 527.24M | 499.00M | 250.73M | 317.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7.84B | 7.37B | 7.01B | 6.95B | 4.24B |
| Total Liabilities | 4.90B | 4.73B | 4.50B | 4.56B | 2.73B |
| Shareholders' Equity | 2.95B | 2.68B | 2.65B | 1.56B | 1.52B |
| Total Debt | 1.75B | 1.80B | 1.40B | 1.83B | 730.98M |
| Cash & Equivalents | 198.40M | 236.98M | 230.59M | 573.58M | 181.53M |
| Current Assets | 3.32B | 3.26B | 3.27B | 2.10B | 2.28B |
| Current Liabilities | 2.82B | 3.41B | 2.89B | 1.73B | 2.02B |